ALOX5AP and acute myeloid leukemia: ROC curve analysis revealed that the AUC value was 0.8770 (95% CI 0.7738–0.9803, P < 0.0001) in our cohort (Fig. 1e), which suggested the ALOX5AP expression level might be a potential biomarker to discriminate AML from controls.